HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Asenbaum Selected Research

2beta- carbomethoxy- 3beta- (4- iodophenyl)tropane (Iometopane)

2/2001[123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa.
2/2001No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: a [(123)I]-beta-CIT SPECt-study.
11/2000[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.
9/2000SPECT and PET imaging of the dopaminergic system in Parkinson's disease.
3/2000[123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Asenbaum Research Topics

Disease

2Seasonal Affective Disorder
11/2001 - 03/2000
1Glioma (Gliomas)
10/2007
1Anxiety Disorders (Anxiety Disorder)
10/2006
1Hemiplegia (Spastic Hemiplegia)
07/2004
1Paresis (Hemiparesis)
07/2004
1Amyloid Plaque
07/2003
1Restless Legs Syndrome (Restless Legs)
08/2002
1Feeding and Eating Disorders (Eating Disorder)
02/2001
1Bulimia (Binge Eating)
02/2001
1Bulimia Nervosa
02/2001
1Tourette Syndrome (Tourette's Syndrome)
02/2001
1Multiple System Atrophy
11/2000
1Corticobasal Degeneration
11/2000
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
11/2000
1Psychotic Disorders (Schizoaffective Disorder)
09/2000
1Essential Tremor (Essential Tremors)
09/2000
1Parkinsonian Disorders (Parkinsonism)
09/2000
1Brain Diseases (Brain Disorder)
09/2000

Drug/Important Bio-Agent (IBA)

52beta- carbomethoxy- 3beta- (4- iodophenyl)tropane (Iometopane)IBA
02/2001 - 03/2000
4Pharmaceutical PreparationsIBA
08/2002 - 03/2000
3Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
11/2001 - 02/2001
2Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
02/2001 - 03/2000
2Serotonin (5 Hydroxytryptamine)IBA
02/2001 - 03/2000
2Dopamine (Intropin)FDA LinkGeneric
02/2001 - 02/2001
1Methionine (L-Methionine)FDA Link
10/2007
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
10/2006
1EscitalopramFDA Link
10/2006
1OximesIBA
07/2004
1Glucose (Dextrose)FDA LinkGeneric
07/2003
1LigandsIBA
07/2003
1Cholinergic Agents (Cholinergics)IBA
07/2003
1Levodopa (L Dopa)FDA LinkGeneric
08/2002
13- iodo- 2- hydroxy- 6- methoxy- N- ((1- ethyl- 2- pyrrolidinyl)methyl)benzamideIBA
08/2002
1A 17 (A-17)IBA
02/2001
1Psychotropic Drugs (Psychoactive Drugs)IBA
02/2001
1Antipsychotic Agents (Antipsychotics)IBA
09/2000